Medicine and Dentistry
Abdominal Aortic Aneurysm
8%
Abdominal Aortic Aneurysm Repair
13%
Adjuvant Chemotherapy
9%
Adjuvant Therapy
17%
Adverse Event
35%
Amputation
23%
Anticoagulation
8%
Aortic Dissection
9%
Apoplexy
36%
Arm
10%
Arteriosclerosis Obliterans
10%
Arteriovenous Fistula
16%
Artery
13%
Assisted Circulation
51%
Asthma in Children
8%
Bleeding
12%
Blood Pressure
11%
Body Mass Index
11%
Cannulation
9%
Cardiac Muscle Cell
9%
Carotid Artery Stenting
8%
Chemoradiotherapy
8%
Clinical Trial
11%
Combination Therapy
13%
Coronary Artery Bypass Graft
39%
Cost-Effectiveness Analysis
8%
COVID-19
21%
Critical Limb Ischemia
9%
Diabetes
15%
Disease
38%
End-Systolic Volume
8%
Endovascular Aneurysm Repair
14%
Erythrocyte Transfusion
11%
Esophageal Adenocarcinoma
8%
Extracorporeal
9%
Extracorporeal Membrane Oxygenation
49%
Functional Status
8%
Gastrointestinal Bleeding
14%
General Anesthesia
9%
Hazard Ratio
28%
Heart Failure
42%
Heart Graft
16%
Heart Left Ventricle Failure
8%
Heart Muscle Ischemia
16%
Heart Surgery
15%
Heart Transplantation
54%
Hemodialysis
26%
Hepatitis C
12%
Hepatitis C Virus
8%
Hospital Mortality
8%
Infection
14%
Infective Endocarditis
8%
Injury
8%
Ischemia
10%
Ischemic Mitral Valve Regurgitation
21%
Left Ventricular Assist Device
100%
Leg Ischemia
8%
Limb
14%
Limb Ischemia
10%
Logistic Regression Analysis
10%
Lung Cancer
19%
Lung Cancer Screening
8%
Mitral Insufficiency
14%
Mitral Valve Repair
18%
Mitral Valve Replacement
15%
Mitral Valve Surgery
8%
Multidetector Computed Tomography
8%
Myocardial Infarction
9%
Myocardium
9%
Neck
8%
Neoadjuvant Therapy
14%
Neoplasm
11%
Non Small Cell Lung Cancer
35%
Obstruction
8%
Odds Ratio
35%
Oncology
9%
Opiate
13%
Overall Survival
12%
Paclitaxel
8%
Pediatrics
14%
Percutaneous Aortic Valve Replacement
22%
Positron Emission Tomography
8%
Prevalence
9%
Proportional Hazards Model
12%
Prosthetics
8%
Quality of Life
10%
Radiation Therapy
20%
Revascularization
23%
Surgeon
29%
Surgery
58%
Systematic Review
14%
Thromboembolism
9%
Thrombosis
18%
Transplantation
31%
Tricuspid Insufficiency
23%
Valve Replacement
8%
Vascular Surgery
21%
Ventricular Assist Device
20%
Ventricular Septal Defect
9%
Wound Infection
8%
Keyphrases
Adverse Events
5%
Anticoagulation
7%
Body Mass Index
8%
Cardiac Transplantation
13%
Cardiopulmonary Bypass
5%
Challenging Patients
6%
Clinical Trials
5%
Confidence Interval
20%
Continuous-flow Left Ventricular Assist Device (CF-LVAD)
17%
Coronary Artery Bypass Grafting
5%
Coronary Artery Disease
5%
COVID-19
9%
Dilated Cardiomyopathy
5%
Donor Heart
5%
Etiology
5%
Extracorporeal Membrane Oxygenation Support
6%
Functional Status
5%
Hazard Ratio
9%
Heart Failure
5%
Heart Transplant
5%
Heart Transplantation
15%
HeartMate II
6%
High Dose
5%
Improved Survival
5%
In-hospital Mortality
7%
Interagency Registry for Mechanically Assisted Circulatory Support
5%
Left Ventricular Assist Device
17%
Left Ventricular Size
5%
Medical Therapy
6%
Mitral Regurgitation
5%
Mitral Valve Repair
17%
P2X7 Receptor (P2X7R)
6%
Postoperative Outcomes
5%
Primary Graft Dysfunction
10%
Red Blood Cell Transfusion
9%
Resection
5%
Restrictive Cardiomyopathy
5%
Risk of Death
6%
Severe Ischemic Mitral Regurgitation
5%
Severe Mitral Regurgitation
5%
Severe Tricuspid Regurgitation
5%
Surgical Options
5%
Surgical Treatment
5%
Transcatheter Aortic Valve Replacement
8%
Transcatheter Intervention
8%
Transcatheter Tricuspid Valve Replacement
8%
Transplantation
6%
Treatment Options
5%
Tricuspid Regurgitation
9%
Tumor Immune Escape
8%
United States
6%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
26%